Thompson Tamar

USNatural personDirector

Insider

Thompson Tamar

USNatural personDirector2 companies · 24mo

Transactions

Issuers

Buys / Sells

0/1

Last tx

27 Feb 2026

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
CATALYST PHARMACEUTICALS, INC.	3,773	reported	08 Dec 2025	tx 12+87,209−3,773
Avidity Biosciences, Inc.	0	reported	27 Feb 2026	tx 14+134,215−134,215

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
27 Feb 2026	OTHER	Avidity Biosciences, Inc.	6,692	—
27 Feb 2026	OTHER	Avidity Biosciences, Inc.	22,000	—	deriv
27 Feb 2026	OTHER	Avidity Biosciences, Inc.	22,000	—	deriv
27 Feb 2026	OTHER	Avidity Biosciences, Inc.	10,034	—

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
CATALYST PHARMACEUTICALS, INC.	3,773	reported	08 Dec 2025	tx 12+87,209−3,773
Avidity Biosciences, Inc.	0	reported	27 Feb 2026	tx 14+134,215−134,215

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
27 Feb 2026	OTHER	Avidity Biosciences, Inc.	6,692	—
27 Feb 2026	OTHER	Avidity Biosciences, Inc.	22,000	—	deriv
27 Feb 2026	OTHER	Avidity Biosciences, Inc.	22,000	—	deriv
27 Feb 2026	OTHER	Avidity Biosciences, Inc.	10,034	—